Clinical Trial Update: Clinical Study of UTAA07 Injection in the Treatment of Hematologic and Lymphatic Systemic Malignancies [EARLY_Phase 1]

View source ↗

Summary

UTAA07 Injection is being studied in an early-phase 1 clinical trial for hematologic and lymphoid malignancies and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Lymphoid Malignancies

Drugs mentioned

• UTAA07

Snippet

Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd. | Conditions: Hematolymphoid Malignancies | EARLY_Phase 1 | Status: RECRUITING